Search Results for Celebrex (Corporate Dealmaker)

Tuesday, November 24,

9:18 am

  • Log in to The Deal Pipeline
  • Subscribe to The Deal magazine
  • Products & services

Corporate Dealmaker: Helping companies succeed in the deal economy.

Syndicate

Subscribe to our RSS feed

Contributors

Search Results

Advanced Search

Sort ByDate Relevance	Search InCorporate Dealmaker The entire Deal Blogs Network

1 result(s) displayed (1 - 1 of 1):

Are method patents still valuable? (from Corporate Dealmaker)

Intellectual property issues are looming larger for most companies, but nowhere do they matter more than in the biotechnology industry. That is why a couple of recent decisions on so-called method patents in biotech have attracted such wide interest - and raised so many questions. The first case involved...

Posted on February 15, 2005 1:43 PM

Movable Type search results powered by Fast Search

Search

Corporate Dealmaker Video

Deal Economy 2010: Morgan Stanley's Smith Barney integration

Morgan Stanley's Rosenthal on the nitty gritty details of the Smith Barney integration.

Movers & Shakers

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.

Juergen Lasowski, Onyx Pharmaceuticals Inc.

Edward Swallow, Northrop Grumman Corp.

Owen Mahoney, Outspark

Alice Kim, FLO TV Inc.

Eric Hausler, Isle of Capri Casinos Inc.

COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine

And the winners are...

Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue